Medical/Pharmaceuticals News & Press Release Distribution

FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke

STATE COLLEGE, Pa., Sept. 13, 2021 /PRNewswire/ -- * FUJIFILM Diosynth Biotechnologies (FDB) will provide essential drug substance and drug product manufacturing, under accelerated timelines, for NeuExcell's first-in-human clinical studies * Drug substance manufacturing will be carried out in...

2021-09-13 18:00 1583

Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors

HOUSTON and SINGAPORE, Sept. 13, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that the U.S. Food and Drug Administration (FDA) has approved the initiation of a Phas...

2021-09-13 17:00 1470

Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets

SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest" or the "Company") announced today two separate definitive agreements ("Agreements") withProvidence Therapeutics Holdings Inc.

2021-09-13 17:00 3852

Harbour BioMed Announces Phase I Study Positive Results on Next-Generation Anti-CTLA-4 Antibody HBM4003

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 13, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced positive results from its phase I dose escalation clinical trial of HBM4003 in solid tumors in Australia (the "phase I study"). The clinical data abstract has...

2021-09-13 14:34 2663

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

INCHEON, South Korea, Sept. 13, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization, announced the signing of an MOU today to participate in the Frontier 1.5D initiative to develop a climate risk management model as part...

2021-09-13 12:41 1291

Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative

Kazia Therapeutics to Present at HC Wainwright 23rd Annual Global Investment Conference

SYDNEY, Sept. 10, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be presenting at the HC Wainwright 23rd Annual Global Investment Conference, to be held virtually from13-...

2021-09-11 00:30 19955

Concord Medical Purchases Additional Proton Therapy System for It's Shanghai Concord Cancer Center

BEIJING, Sept. 10, 2021 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education, and prevention by establishing proton centers and specialty cancer hospitals and operatin...

2021-09-10 19:02 14074

Senhwa Announces First Patient Successfully Dosed in Phase 1b Expansion Study of Pidnarulex to Treat Solid Tumors with Specific Homologous Recombination Gene Mutations

TAIPEI and SAN DIEGO, Sept. 10, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced t hat their first patient has been successfully dosed, in a Phase1b c...

2021-09-10 19:00 14942

Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market

SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), an internet technology company offering healthcare professionals the online healthcare information, professional training and educational services platform and patients the patient management ...

2021-09-10 18:30 3707

3DMed Diagnostics Donates Medical Supplies to Support COVID-19 Fight in Cambodia

SHANGHAI, Sept. 10, 2021 /PRNewswire/ -- Shanghai-based biotechnology company, 3DMed Diagnostics, has donated anti-coronavirus medical appliances worth US$218,000 to Cambodia's Ministry of Health to support its campaign against COVID-19. A handover ceremony was held onFriday September 3 via video ...

2021-09-10 18:22 2444

3DMed Diagnostics Donates Medical Supplies to Support COVID-19 Fight in Cambodia

Cytiva triples single-use consumables capacity in China

* Three new manufacturing lines were successfully launched in under ten months, with an additional eight new lines planned to launch in Q3 2022. * Sustain and secure the supply chain for customers in China and the broader region. * With the use of Fortem™ film, Cytiva helps customers speed...

2021-09-10 16:33 2481

Cytiva triples single-use consumables capacity in China

Winner Medical Celebrates 30th Anniversary with Continued Focus on Sustainable Development

SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ -- Winner Medical Co., Ltd. (300888.SZ), a leading manufacturer of high-quality medical and consumer products, celebrates its 30th anniversary this year alongside the release of its first annual corporate social responsibility report which highlights i...

2021-09-10 14:44 4045

Winner Medical Celebrates 30th Anniversary with Continued Focus on Sustainable Development

Mindray Brings Increased Clinical Efficiency and Diagnostic Confidence to Medical Industry with New TE9 POC Ultrasound System

SHENZHEN, China, Sept. 10, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has today announced the launch of its latest Point-of-Care (POC) ultrasound system, the TE9, featuring a larger screen for enhanced viewing, intelligen...

2021-09-10 13:00 2414

DiaCarta Receives CE/IVD for its New COVID 19 Screening Test that Identifies Delta Plus and New Variants

PLEASANTON, Calif., Sept. 10, 2021 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel oncology tests using liquid biopsy today announced that its new QuantiVirus™ SARS-CoV-2 Variant Detection Test received the CE/IVD marking and therefore, can ...

2021-09-10 02:02 2077

Yuyu Pharma Receives ISO 37001 Anti-Bribery Management System Certification

SEOUL, South Korea, Sept. 9, 2021 /PRNewswire/ -- Yuyu Pharma (KRX: 000220) received the ISO 37001 Anti-Bribery Management System (ABMS) certification from the British Standards Institution (BSI) inAugust 2021. Chief Executive Officer Robert Wonsang Yu said "we believe that the certification is a...

2021-09-09 21:00 1626

Yuyu Pharma Receives ISO 37001 Anti-Bribery Management System Certification

Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices

Integration enables comprehensive visibility, enhanced risk management and security enforcement BROOKLYN, N.Y., Sept. 9, 2021 /PRNewswire/ -- Medigate, healthcare's Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered e...

2021-09-09 21:00 1867

Medigate and CrowdStrike to Provide Healthcare Organizations with Unified Endpoint Security for Medical IoT Devices

Integration enables comprehensive visibility, enhanced risk management and security enforcement BROOKLYN, N.Y., Sept. 9, 2021 /PRNewswire/ -- Medigate, healthcare's Best in KLAS IoT Security Provider, today announced it has partnered with CrowdStrike, a leading provider of cloud-delivered e...

2021-09-09 20:51 1599

Sofwave Medical Appoints Assaf Korner as Chief Financial Officer

TUSTIN, Calif., Sept. 9, 2021 /PRNewswire/ -- Sofwave Medical LTD (TASE: SOFW) ("Sofwave" or the "Company"), a medical device aesthetic innovator in the non-invasive skin treatments, today announced the appointment of Assaf Korner as Chief Financial Officer, succeedingMichael Eden effective Septem...

2021-09-09 20:11 1772

PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer

DAEJEON, South Korea, Sept. 9, 2021 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, today announced it submitted a Patent Cooperation Treaty (PCT) application for the combination therapy of...

2021-09-09 20:00 1434

Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine

CHENGDU, China, Sept. 9, 2021 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd. (Clover) , a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced that its wholly-owned subsidiary, Zhejiang Clover...

2021-09-09 19:51 1882